BRPI0309001A2 - bactérias gram-negativas atenuadas - Google Patents
bactérias gram-negativas atenuadasInfo
- Publication number
- BRPI0309001A2 BRPI0309001A2 BRPI0309001A BRPI0309001A BRPI0309001A2 BR PI0309001 A2 BRPI0309001 A2 BR PI0309001A2 BR PI0309001 A BRPI0309001 A BR PI0309001A BR PI0309001 A BRPI0309001 A BR PI0309001A BR PI0309001 A2 BRPI0309001 A2 BR PI0309001A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterium
- negative bacteria
- mutant
- attenuated gram
- disclosed
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 230000002238 attenuated effect Effects 0.000 title abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37028202P | 2002-04-05 | 2002-04-05 | |
| US60/370,282 | 2002-04-05 | ||
| US10/406,686 US7449178B2 (en) | 2002-04-05 | 2003-04-03 | Attenuated gram negative bacteria |
| US10/406,686 | 2003-04-03 | ||
| PCT/US2003/010308 WO2003086277A2 (en) | 2002-04-05 | 2003-04-04 | Attenuated gram negative bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0309001A2 true BRPI0309001A2 (pt) | 2017-07-04 |
| BRPI0309001B1 BRPI0309001B1 (pt) | 2021-11-30 |
Family
ID=29254405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0309001-9A BRPI0309001B1 (pt) | 2002-04-05 | 2003-04-04 | Bactérias gram-negativas atenuadas |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7449178B2 (pt) |
| EP (1) | EP1575483B1 (pt) |
| JP (1) | JP4338528B2 (pt) |
| KR (1) | KR101037566B1 (pt) |
| CN (2) | CN1934240A (pt) |
| AT (1) | ATE518955T1 (pt) |
| AU (2) | AU2003223447C1 (pt) |
| BR (1) | BRPI0309001B1 (pt) |
| CA (1) | CA2481186C (pt) |
| CO (1) | CO5640065A1 (pt) |
| ES (1) | ES2371498T3 (pt) |
| HK (1) | HK1078271A1 (pt) |
| MX (1) | MXPA04009730A (pt) |
| NZ (1) | NZ535993A (pt) |
| PT (1) | PT1575483E (pt) |
| WO (1) | WO2003086277A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060099543A (ko) * | 1994-12-09 | 2006-09-19 | 임페리얼 컬리지 이노베이션스 리미티드 | 유전자의 동정 |
| CA2341349C (en) * | 1998-09-04 | 2013-12-10 | Creatogen Aktiengesellschaft | Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| GB9910812D0 (en) * | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
| US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
| EP1914239B1 (en) * | 2002-04-05 | 2010-06-09 | Merial | Attentuated gram negative bacteria |
| BRPI0410911B1 (pt) * | 2003-07-02 | 2014-07-08 | Biotechnology Res & Dev | Mutantes acapsulares de p. multocida por deleção de hyae |
| AU2005331860B2 (en) * | 2004-12-22 | 2011-08-11 | Intervet International B.V. | Pasteurella multocida vaccine |
| US8703153B2 (en) | 2008-06-16 | 2014-04-22 | Prokarium Ltd. | Salmonella vectored vaccines against Chlamydia and methods of use |
| US8917497B2 (en) * | 2012-07-23 | 2014-12-23 | Knaack Llc | Jobsite storage cabinet for housing electronic equipment |
| WO2015066292A1 (en) | 2013-11-01 | 2015-05-07 | Merial Limited | Attenuated pasteurella multocidavaccines & methods of making & use thereof |
| WO2016049917A1 (en) * | 2014-09-30 | 2016-04-07 | Bgi Shenzhen Co., Limited | Biomarkers for obesity related diseases |
| TW202219269A (zh) * | 2020-09-30 | 2022-05-16 | 美國農業部 | 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗 |
| WO2022072431A1 (en) * | 2020-09-30 | 2022-04-07 | Zoetis Services Llc | Novel pasteurella multocida strains and vaccines having hyac and nanp deletions |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0668779A4 (en) * | 1992-11-06 | 1996-08-21 | Univ Minnesota | Vaccine to protect against pasteurellosis - infection by P.multocida. |
| US6793927B1 (en) * | 1993-12-06 | 2004-09-21 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
| KR20060099543A (ko) | 1994-12-09 | 2006-09-19 | 임페리얼 컬리지 이노베이션스 리미티드 | 유전자의 동정 |
| US6770275B1 (en) * | 1996-05-31 | 2004-08-03 | Akzo Nobel N.V. | Live attenuated RTC-producing bacteria of the family |
| US6086894A (en) * | 1996-06-27 | 2000-07-11 | Virginia Tech Intellectual Properties, Inc. | Recombinant vaccine for diseases caused by encapsulated organisms |
| US6783764B1 (en) * | 1997-04-10 | 2004-08-31 | Akzo Nobel Nv | Actinobacillus pleuropneumoniae subunit vaccine |
| CH692179A5 (de) | 1997-06-25 | 2002-03-15 | Kueschall Design Ag | Rollstuhl und Sitzmodul für den Rollstuhl, |
| US20010018055A1 (en) * | 1997-09-25 | 2001-08-30 | Briggs Robert E. | Deletion mutants of virulence factors of pasteurellaceae |
| KR20060134225A (ko) | 1999-04-09 | 2006-12-27 | 파마시아 앤드 업존 캄파니 엘엘씨 | 항균성 백신 조성물 |
| US6790950B2 (en) * | 1999-04-09 | 2004-09-14 | Pharmacia & Upjohn Company | Anti-bacterial vaccine compositions |
| GB9910812D0 (en) * | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
| US6780405B1 (en) * | 2000-04-28 | 2004-08-24 | Avant Immunotherapeutics, Inc. | Regulated antigen delivery system (RADS) |
| WO2002018601A2 (en) * | 2000-08-25 | 2002-03-07 | Abbott Laboratories | Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes' |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
| US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
| EP1914239B1 (en) * | 2002-04-05 | 2010-06-09 | Merial | Attentuated gram negative bacteria |
| EP1608676A2 (en) * | 2003-03-27 | 2005-12-28 | Children's Hospital, Inc. | Nontypeable haemophilus influenzae virulence factors |
| UA100370C2 (uk) * | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
| TWI328458B (en) * | 2007-03-09 | 2010-08-11 | Univ Nat Chunghsing | Subunit vaccine of pasteurella multocida in veterinary uses |
-
2003
- 2003-04-03 US US10/406,686 patent/US7449178B2/en not_active Expired - Lifetime
- 2003-04-04 CN CNA038123800A patent/CN1934240A/zh active Pending
- 2003-04-04 PT PT03719577T patent/PT1575483E/pt unknown
- 2003-04-04 BR BRPI0309001-9A patent/BRPI0309001B1/pt not_active IP Right Cessation
- 2003-04-04 WO PCT/US2003/010308 patent/WO2003086277A2/en active Application Filing
- 2003-04-04 EP EP03719577A patent/EP1575483B1/en not_active Expired - Lifetime
- 2003-04-04 AU AU2003223447A patent/AU2003223447C1/en not_active Expired
- 2003-04-04 MX MXPA04009730A patent/MXPA04009730A/es active IP Right Grant
- 2003-04-04 KR KR1020047015890A patent/KR101037566B1/ko active IP Right Grant
- 2003-04-04 AT AT03719577T patent/ATE518955T1/de active
- 2003-04-04 NZ NZ535993A patent/NZ535993A/en not_active IP Right Cessation
- 2003-04-04 CA CA2481186A patent/CA2481186C/en not_active Expired - Lifetime
- 2003-04-04 CN CN2011104311167A patent/CN102864090A/zh active Pending
- 2003-04-04 JP JP2003583304A patent/JP4338528B2/ja not_active Expired - Lifetime
- 2003-04-04 ES ES03719577T patent/ES2371498T3/es not_active Expired - Lifetime
-
2004
- 2004-11-04 CO CO04111105A patent/CO5640065A1/es not_active Application Discontinuation
-
2005
- 2005-12-02 HK HK05111055.4A patent/HK1078271A1/xx not_active IP Right Cessation
-
2008
- 2008-10-07 US US12/246,809 patent/US7943125B2/en not_active Expired - Lifetime
-
2010
- 2010-08-04 AU AU2010206113A patent/AU2010206113B2/en not_active Expired
-
2011
- 2011-04-20 US US13/091,046 patent/US8329163B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1078271A1 (en) | Attenuated gram negative bacteria | |
| BR0210216A (pt) | Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante | |
| DK0721506T3 (da) | Bakterielle eksporterede proteiner og acellulære vacciner baseret derpå | |
| MX9705727A (es) | Variantes de amilasa. | |
| GEP20032977B (en) | Proteinase K-Resistant Surface Protein of Neisseria Meningitidis | |
| NZ549873A (en) | Compounds and methods for treatment and diagnosis of chlamydial infection by stimulating an immune response | |
| AU2002345084A1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene | |
| IL175319A0 (en) | Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof | |
| IL162917A0 (en) | A lysin from bacteriophage and pharmaceutical compositions containing the same | |
| ES2535961T3 (es) | Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia | |
| Sauerborn et al. | Nucleotide sequence of Clostridium difficile toxin A. | |
| CY1108972T1 (el) | Εξασθενημενα αρνητικα κατα gram βακτηρια | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| DK0892054T3 (da) | Clostridium perfringens-vaccine | |
| BR0314255A (pt) | Método de preparação de uma queratinase, bacillus recombinante, cultura bacteriana, e, método de preparação de um bacillus recombinante | |
| BR9506038A (pt) | Dna clonato vetor recombinante e planta | |
| KR930013104A (ko) | 세르풀리나 하이오다이센테리애 백신 | |
| Torelli et al. | Draft genome of a Xanthomonas perforans strain associated with pith necrosis | |
| NZ511166A (en) | Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B | |
| NO20025126L (no) | (R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme | |
| EP1158052A4 (en) | BETA-PRIMEVEROSIDASDE GENE | |
| GB9027901D0 (en) | Acellular vaccine | |
| TH53371B (th) | ลำดับนิวคลิโอไทด์ใหม่ซึ่งใส่รหัสสำหรับจีน cls |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: MERIAL, INC. (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/04/2003, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
| B25A | Requested transfer of rights approved |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US) |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 04/04/2023 |